FibroBiologics amends 8-K to disclose up to 41.4M shares issuable under SEPA with YA II PN

FibroBiologics, Inc.

Maximum shares convertible from $15M promissory notes: 36,945,812 shares at $0.406/share.
Additional maximum shares from Commitment Amount: 4,424,778 shares at $2.26/share.
Agreement with YA II PN, Ltd. was previously disclosed on Dec 20, 2024; amendment adds share counts.
Conversion price subject to anti-dilution adjustments; shares unregistered under Securities Act.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.